Comparison of Fasting Blood Glucose Measurements From Fingertip and Intravenous on Patient Satisfaction in Patients With Diabetes Mellitus

NCT ID: NCT05976191

Last Updated: 2023-08-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

110 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-01

Study Completion Date

2023-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study was designed as a randomized controlled experimental study in order to compare the fasting blood glucose values measured by puncturing the fingertips and using the intravenous route of patients diagnosed with diabetes mellitus, and to determine the effect on patient satisfaction. The blood glucose measurement via the intravenous catheter has an effect on increasing the comfort of the patient compared to the fingertip measurement. It is thought that information can be provided to increase patient satisfaction.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Crossover Assignment This research was designed in a pretest posttest randomized controlled experimental type
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants
Single (Participant) Identity information of the patients was concealed and verbal and written consents were obtained.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

experimental group

Patients whose blood glucose is measured intravenously and from the fingertip

Group Type EXPERIMENTAL

Patients whose blood glucose is measured intravenously and from the fingertip

Intervention Type BEHAVIORAL

A satisfaction survey will be conducted after these patients have previously examined their blood glucose via intravenous route, then fingertip blood glucose will be measured and a satisfaction survey will be applied.

control group

Patients with fingertip blood glucose measurement

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Patients whose blood glucose is measured intravenously and from the fingertip

A satisfaction survey will be conducted after these patients have previously examined their blood glucose via intravenous route, then fingertip blood glucose will be measured and a satisfaction survey will be applied.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years and older
* No advanced hearing and vision problems
* Able to speak and understand Turkish
* Easy to communicate
* literate
* Agreeing to participate in the research voluntarily
* Patients who are hospitalized
* Regular finger blood sugar monitoring,
* Patients with an intravenous vascular access date within the first 24 hours
* Patients who had been diagnosed with Type 2 Diabetes Mellitus for at least one year were.

Exclusion Criteria

* Those who are treated with sedative drugs
* Patients using antipsychotic medication
* Patients with continuous drug infusion through the intravenous line
* Patients whose intravenous vascular access date has passed 24 hours
* Patients in unconscious, confused, apathetic state
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Istanbul University - Cerrahpasa

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

AYSEGUL

principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Istanbul University-Cerrahpaşa (IUC)

Istanbul, Şişli, Turkey (Türkiye)

Site Status RECRUITING

Istanbul University-Cerrahpaşa (IUC)

Istanbul, Şişli, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

AYSEGUL OZBAKAN

Role: primary

00905423047687

ARZU ERKOC

Role: backup

00905552735500

AYSEGUL OZBAKAN

Role: primary

05423047687

ARZU ERKOÇ

Role: backup

05552735500

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022/476

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.